Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jan 1;97(1):157-164.
doi: 10.1002/ccd.28969. Epub 2020 Jun 4.

Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes

Alexandra C Murphy  1   2 , Anoop N Koshy  1   2 , William Cameron  1 , Mark Horrigan  1 , Leighton Kearney  1   2 , Belinda Yeo  3 , Omar Farouque  1   2 , Matias B Yudi  1   2
Affiliations
Meta-Analysis

Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes

Alexandra C Murphy et al. Catheter Cardiovasc Interv. .

Abstract

Background: A history of cancer is incorporated into the surgical risk assessment of patients undergoing surgical aortic valve replacement through the Society for Thoracic Surgeons score. However, the prognostic significance of cancer in patients treated with transcatheter aortic valve replacement (TAVR) is unclear. As the cancer survivorship population increases, it is imperative to establish the efficacy and safety of TAVR in patients with severe symptomatic aortic stenosis (AS) and a history of malignancy.

Objectives: The primary goal of this study was to assess the periprocedural outcomes and long-term mortality in patients with a history of cancer undergoing TAVR.

Methods: A systematic review of PubMed, MEDLINE, and EMBASE was conducted to identify studies reporting outcomes in patients with a history of malignancy undergoing TAVR. A meta-analysis was performed using a random-effects model with a primary outcome of all-cause mortality and cardiac mortality at the longest follow-up. On secondary analyses, procedural safety was assessed.

Results: A total of 13 observational studies with 10,916 patients were identified in the systematic review. Seven studies including 6,323 patients were included in the quantitative analysis. Short-term mortality (relative risk [RR] 0.61, 95%CI 0.36-1.01; p = .06) and long-term all-cause mortality (RR 1.24, 95%CI 0.95-1.63; p = .11) were not significantly different when comparing patients with and without a history of cancer. No significant difference in the rate of periprocedural complications including stroke, bleeding, acute kidney injury, and pacemaker implantation was noted.

Conclusion: In patients with severe AS undergoing TAVR, a history of cancer was not associated with adverse short or long-term survival. Based on these findings, TAVR should be considered in all patients with severe symptomatic AS, irrespective of their history of malignancy.

Keywords: aortic valve disease; comparative effectiveness/patient-centered outcomes research; percutaneous intervention; transcatheter valve implantation.

PubMed Disclaimer

Comment in

  • TAVR in cancer; healing the sickest of the sick.
    Marmagkiolis K, Cilingiroglu M. Marmagkiolis K, et al. Catheter Cardiovasc Interv. 2021 Jan 1;97(1):165-166. doi: 10.1002/ccd.29445. Catheter Cardiovasc Interv. 2021. PMID: 33460266 No abstract available.

References

REFERENCES

    1. Rozhok AI, DeGregori J. The evolution of lifespan and age-dependent cancer risk. Trends Cancer. 2016;2(10):552-560.
    1. Baumgartner H. Aortic stenosis: medical and surgical management. Heart. 2005;91(11):1483-1488.
    1. Agrawal N, Kattel S, Singh V, et al. Prognostic impact of prior radiation exposure in cancer survivors with severe aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2019;73(9):1093.
    1. Hayek SS, Ganatra S, Lenneman C, et al. Preparing the cardiovascular workforce to care for oncology patients: JACC review topic of the week. J Am Coll Cardiol. 2019;73(17):2226-2235.
    1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.

MeSH terms